№ lp_1_2_31477
File format: docx
Character count: 13777
File size: 57 KB
The document provides a standard operating procedure for safely handling and working with diphtheria toxin in biomedical research, outlining risk assessment, safety measures, and guidelines for toxin preparation and use in laboratory settings.
Note:
Year
Topic:
Diphtheria Toxin Handling and Safety Protocol
Document Type:
Standard Operating Procedure
Target Audience:
Researchers, Laboratory Personnel
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
England
Topic:
Immunisation
Document Type:
Patient Group Direction (PGD)
Organisation / Institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Rebecca Cordery, Greta Hayward
Target Audience:
Healthcare practitioners
Period of Validity:
From 1 November 2025 to 1 November 2028
Approval Date:
24 September 2025
Revision Date:
23 September 2025
Year:
2023
Region / City:
Berkeley, CA
Topic:
Biosafety, Laboratory Procedures, Toxicology
Document Type:
Standard Operating Procedure (SOP)
Institution:
University of California, Berkeley
Author:
EH&S
Target Audience:
Researchers, Laboratory Personnel, Biosafety Officers
Period of Validity:
Ongoing
Approval Date:
2023
Amendment Date:
Not provided
Year:
2024
Region / City:
United States
Topic:
Vaccination Protocol
Document Type:
Medical Protocol
Organization / Institution:
American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP)
Author:
Prescriber
Target Audience:
Healthcare professionals
Period of validity:
Indefinite until rescinded
Approval Date:
March 26, 2024
Date of changes:
Not specified
Year:
2015
Region / city:
United Kingdom
Topic:
Immunisation
Document type:
Public Health Guideline
Organization / institution:
Public Health England
Author:
Elizabeth Graham, Mary Ramsay, David Green
Target audience:
Healthcare professionals, Registered Nurses, Paramedics
Period of validity:
From 15 December 2015 to 30 November 2017
Approval date:
15 December 2015
Amendment date:
N/A
Expiry date:
30 November 2017
Version:
v01.00
Review date:
1 June 2017
Reference number:
DTaP/IPV/Hib PGD
Note:
Change history
Version 1.00:
New PHE PGD template, 15 December 2015
Year:
2022
Region / country:
United Kingdom
Topic:
Public health; infectious disease prevention
Document type:
Patient Group Direction (PGD)
Organization:
UK Health Security Agency (UKHSA)
Authors:
Jacqueline Lamberty, Mary Ramsay, Kate Wedgwood
Target audience:
Registered healthcare practitioners
Valid from:
21 November 2022
Review date:
21 May 2024
Expiry date:
20 November 2024
Version:
02.00
Changes history:
Removal of Sandoz as exclusive brand, addition of off-label use for Pfizer suspension, guidance for suspension handling
Authorization requirements:
Named practitioner authorization under current PGD version, organizational sign-off according to HMR2012
Training requirements:
Competency in PGDs, product familiarity, local policy training compliance
Source type:
Regulatory/healthcare guidance document
PGD development:
Peer-reviewed by expert panel and ratified by UKHSA Clinical Quality Oversight Board
Year:
2026
Region / City:
University of Washington
Theme:
Select Toxin Transfer, Due Diligence
Document Type:
Form
Organization / Institution:
University of Washington, Environmental Health & Safety
Author:
Not specified
Target Audience:
Researchers, Laboratory Personnel
Period of Validity:
Indefinite
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2026
Institution:
Duke University
Document Type:
Standard Operating Procedure (SOP)
Subject:
Pertussis toxin handling and safety
Author:
Not specified
Approval:
OESO SOP Approval Date provided
Intended Audience:
Laboratory personnel working with pertussis toxin
Hazard Classification:
Acute toxicity (oral, inhalation, dermal), eye irritation
Biosafety Level:
BSL-2 precautions recommended
Storage Conditions:
4°C in original container, secondary shatterproof container
Preparation Area:
Class II Biological Safety Cabinet (BSC) or Chemical Fume Hood (CFH)
Routes of Exposure:
Skin, inhalation, ingestion, injection
Emergency Procedures:
First aid and exposure response protocols specified
Year:
2023
Region / City:
Berkeley, CA
Topic:
Biosafety, Laboratory Procedures, Toxicology
Document Type:
Standard Operating Procedure (SOP)
Institution:
University of California, Berkeley
Author:
EH&S
Target Audience:
Researchers, Laboratory Personnel, Biosafety Officers
Period of Validity:
Ongoing
Approval Date:
2023
Amendment Date:
Not provided
Document Type:
Administrative form and procedural guideline
Subject:
Destruction of Select Agent Toxins
Regulatory Reference:
42 CFR 73.7(h); 42 CFR 73.21
Responsible Office:
Environmental Health and Safety (EH&S)
Related Authority:
U.S. Department of Health and Human Services
Applicable To:
Principal Investigators and laboratory personnel handling Select Agents or Toxins
Destruction Methods:
Chemical inactivation (sodium hypochlorite); autoclave heat treatment
Safety Requirements:
Laboratory hood or biological safety cabinet; specified personal protective equipment
Notification Requirement:
Written notice five business days prior to destruction
Witness Requirement:
EH&S staff member
Disposal Procedure:
Collection and disposal by Environmental Health and Safety
Contact Information:
Biosafety Office 928-523-7268
Year:
Not specified
Region / City:
Not specified
Subject:
Ophthalmology, Botulinum Toxin Therapy
Document Type:
Training Document
Organization:
Not specified
Author:
Not specified
Target Audience:
Orthoptists seeking training in botulinum toxin injections
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Organization:
STATDDS
Associated Organizations:
Merz; Allergan; Henry Schein; AAFE; BD
Products Mentioned:
Xeomin; Belotero Balance; Radiesse; Botox; Juvederm; Voluma; Comfortox Syringes; Bacteriostatic 0.9% Sodium Chloride; Alcohol Prep Pads
Document Type:
Product and Ordering Information Sheet
Industry:
Medical and Dental Aesthetics
Intended Audience:
Dental Professionals; Medical Professionals; Clinicians
Distribution Information:
Exclusive dental distribution of specified products by STATDDS
Contact Information:
800-693-9076; [email protected]
Note:
; 866-862-1211; 800-347-4500
Website:
STATDDS.com
Supplies Covered:
Syringes for reconstitution and injection; starter kits; bacteriostatic saline; ice packs; sterile needles
Packaging Details:
Individual sterile packaging; box quantities; vial quantities
Order References:
Henry Schein Order #890-8538; #104-6851; #987-8204; #987-1329
Year:
2023
Region / City:
USA
Topic:
Biosafety, Laboratory Protocols
Document Type:
Safety Manual
Organization / Institution:
University of Southern California
Author:
Unknown
Target Audience:
Laboratory Personnel
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
Not specified
Institution:
University of Florida
Department / Unit:
Environmental Health and Safety (EHS)
Document Type:
Standard Operating Procedure
Topic:
Laboratory biosafety and handling of pertussis toxin in animal research
Biological Agent:
Pertussis toxin
Source Organism:
Bordetella pertussis
Animal Model:
Rodents
Responsible Role:
Principal Investigator and laboratory staff
Related Policy:
Policy on Handling Animals Exposed to Biological Hazards
Required Approval:
Animal Use Protocol (AUP)
Engineering Controls:
Animal Transfer Station (ATS), Biosafety Cabinet (BSC), Chemical Fume Hood (CFH)
Personal Protective Equipment:
Lab attire, eye protection, long-sleeve gown or dedicated lab coat, single gloves
Clear Time After Administration:
72 hours
Waste Decontamination Methods:
Autoclaving at 121°C and 15 psi for 60 minutes or chemical inactivation with sodium hypochlorite
Emergency Contacts:
Environmental Health and Safety, University Police Department, Poison Control Center
Year:
2026
Location:
United States
Subject:
Veterinary Medicine, Nephrology
Document Type:
Research Article
Institutions:
The Ohio State University; University of Georgia; Oregon State University
Authors:
Rene Paschall, Jessica Quimby, Bianca Lourenço, Stacie Summers, Chad Schmiedt
Species Studied:
Domestic Cats
Sample Size:
14
CKD Stages:
IRIS Stage 2 and 3
Treatment:
Porus® One, oral adsorbent, 500 mg daily
Study Period:
112 days
Measurements:
Serum indoxyl sulfate, p-cresyl sulfate, Doppler blood pressure, biochemistry, urinalysis, urine protein:creatinine ratio
Study Design:
Prospective cross-sectional study
Year:
2023
Region / City:
N/A
Topic:
Registration Service, Operational Choreography
Document Type:
Change Request
Organization:
MHHS Programme
Author:
N/A
Target Audience:
Programme Participants
Period of Validity:
N/A
Approval Date:
08/02/2023
Date of Changes:
N/A
Organization:
United Nations Development Programme
Country:
Kuwait
Document type:
Standard Operating Procedures
Subject area:
Project cycle management
Implementation modality:
National Implementation Modality with Country Office support
Strategic framework:
UNDP Strategic Plan 2014–2017
Programme framework:
Country Programme Document and Country Programme Action Plan 2015–2018
Responsible institution:
UNDP Kuwait Country Office
Government coordinating agency:
General Secretariat of the Supreme Council for Planning and Development
Scope:
UNDP programmes and projects implemented in Kuwait
Project phases covered:
Formulation, appraisal, implementation, monitoring, evaluation, extension and closure
Intended users:
UNDP staff and national implementing partners
Annexes included:
Capacity assessment checklist, project document template, risk logs template, quality assurance checklist
Year:
Contract Year No.
Supplier:
Legal Name of Supplier
Facility:
Name of Facility
Contract:
Contract Title / Contract ID
Contract Date:
Contract Date
Time Period:
From insert date To insert date
Contract Capacity (MW):
Contract Capacity
Planned Outages:
As specified per unit and month
Unplanned Outages:
Percentage per unit and month
Overall Availability:
Percentage per unit and month
Type of Document:
Prescribed Form – Annual Operating Plan
Audience:
Buyer and Contract Management
Source:
Independent submission under Section 14.3(b)(i) of the Contract
Note:
Year
Issuing authority:
Ministry for Primary Industries
Jurisdiction:
New Zealand
Legal basis:
Biosecurity Act 1993
Document type:
Operating manual
Facility type:
Transitional Facility for uncleared risk goods
Approval status:
Approved Transitional Facility
Regulatory standards referenced:
TFGEN (Standard for General Transitional Facilities for Uncleared Risk Goods)
Scope of activities:
Receipt, holding, processing, treatment and inspection of uncleared risk goods; inspection of imported containers
Responsible roles:
Transitional Facility Operator; Deputy Transitional Facility Operator; Accredited Person
Compliance requirements:
MPI inspection and verification audits; access for MPI Inspectors at any reasonable time
Version control:
Review and amendments record with dates and sections
Training requirements:
MPI-approved training and refresher training for operators and accredited persons
Operational areas covered:
Security, biosecurity equipment, inspections, record keeping, hygiene management, pest control, audits, contingency plans